NYBC Ventures
Venture Capital And Private Equity Principals
Critical Challenges in These Fields. Its Mission Is to Improve Patient Outcomes by Supporting Groundbreaking Therapeutics
9 employees
- Employees
- 9
- Contacts
- 3
- Emails
- 3
- Phones
- 1
NYBC Ventures Overview
- Headquarters
- Critical Challenges in These Fields. Its Mission Is to Improve Patient Outcomes by Supporting Groundbreaking Therapeutics
- Website
- www.nybcventures.com
- Industry
- Venture Capital And Private Equity Principals
- Employees
- 9
- Founded
- 2022
- NAICS
-
Miscellaneous Intermediation
Keywords
About NYBC Ventures
NYBC Ventures is an early-stage life sciences investment fund dedicated to advancing innovations in blood and cellular therapies. The fund invests in therapeutics, devices, and cutting-edge technologies that address critical challenges in these fields. Its mission is to improve patient outcomes by supporting groundbreaking therapeutics, platforms, and collaborative efforts.
NYBC Ventures Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 1
- 25.0% coverage
NYBC Ventures Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Christopher D. Hillyer, Md | President and CEO, New York Blood | New York City Metropolitan Area, United States |
Email
|
| Kuan Yu | Senior Analyst at Nybc Ventures | New York, United States |
Email
|
| Meg Wood | Managing Director & SVP | Boston, Massachusetts, United States |
Email
Phone
|
| Susannh Sepulveda |
View
|
Employees by Management Level
Executive
1 profile
Director
1 profile
Senior / Lead
1 profile
Compare Similar Companies to NYBC Ventures
Blackstone
Financial Services
New York Blood Center
Hospitals And Health Care
Novo Holdings
Financial Services
Eight Roads
Venture Capital And Private Equity Principals
The Dedham Group
Business Consulting And Services
F-Prime
Venture Capital And Private Equity Principals
Vitestro
Medical Equipment Manufacturing
Comprehensive Cell Solutions (CCS)
Biotechnology Research
Agent Capital
Venture Capital And Private Equity Principals
Sonder Capital
Venture Capital And Private Equity Principals